Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analyst says Aeterna Zentaris shares could double on cancer drug development and approval
Analyst says Aeterna Zentaris shares could double on cancer drug development and approval
Analyst says Aeterna Zentaris shares could double on cancer drug development and approval
Submitted by
admin
on June 7, 2011 - 9:51am
Source:
Yahoo/AP
News Tags:
Aeterna Zentaris
perifosine
Headline:
Analyst says Aeterna Zentaris shares could double on cancer drug development and approval
Do Not Allow Advertisers to Use My Personal information
